Division of Cardiology Research
NYU Langone’s Leon H. Charney Division of Cardiology is home to vibrant basic and translational and clinical research programs. Over the past several decades, our research has contributed substantially to the cardiovascular literature and greatly influenced the practice of cardiology.
Scientists in our new Cardiovascular Research Center conduct basic and translational research to develop a better understanding of the genetic and molecular mechanisms of cardiovascular disease.
The Cardiovascular Clinical Research Center offers scientists throughout our division and within many of our programs and specialties the resources to coordinate multicenter, randomized clinical studies and registries. Our faculty conduct trials on topics such as ischemic heart disease, women’s health, and geriatric health, among many other areas of cardiovascular medicine. Our division faculty also collaborate with researchers in the Division of Adult Cardiac Surgery, part of the Department of Cardiothoracic Surgery, to conduct heart valve disease clinical trials.
Researchers in the Center for the Prevention of Cardiovascular Disease study the cellular and molecular mechanisms of cardiovascular disease and conduct clinical trials on how to prevent and reverse clotting disorders, hypertension, and hypercholesterolemia.
Our division’s research is supported by numerous grants from the National Institutes of Health (NIH); other federal, state, and local agencies; and biomedical research foundations like the American Heart Association, Burroughs Wellcome Fund, and Doris Duke Charitable Foundation, as well as by pharmaceutical and biotechnology companies. We received a remarkable $25 million in externally funded grant support, with more than $150 million in total committed project funds for active awards. These project awards include the NIH T32 Training Program in Cardiometabolic Diseases, the NIH S10 High-Resolution Ultrasound Shared and High-End Instrumentation Award, and the NIH award for the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial.